Allergan Pharmaceuticals Inc v Alcon Laboratories (Australia) Pty Ltd

Link copied
Case Copied 13 min read

PATENTS ACT 1990

DECISION OF A DELEGATE OF THE COMMISSIONER OF PATENTS

Re:Patent Application No 588049 by ALLERGAN PHARMACEUTICALS INC, Opposition by ALCON LABORATORIES (AUSTRALIA) PTY LTD and Objection to Extension of Time to Serve Evidence-in-Support

Background

Allergan Pharmaceuticals Inc (Allergan) lodged application 588049 on 20 August 1986 for an invention relating to cleaning contact lenses.  The Office advertised acceptance of the application on 7 September 1989.  Notices of opposition were lodged by Pilkington Visioncare Inc and by Alcon Laboratories (Australia) Pty Ltd (Alcon).  This decision relates to the latter opposition.
          The initial date for serving evidence-in-support was 6 March 1990 but Alcon was allowed three extensions of time to 6 December 1990, each extension being for three months.  Alcon served three lots of evidence on Allergan during that time.
          Alcon then lodged on 6 December 1990 an application for extension of time to 6 February 1991, and served a fourth lot of evidence on 10 December 1990.  Allergan objected to this extension and the matter was heard in Canberra on 29 January 1991.  The hearing officer allowed the extension in his decision dated 5 April 1991.
          On 6 February 1991 Alcon lodged another application for extension of time to 6 May 1991 which was accompanied by a fifth lot of evidence.  Allergan did not object to this extension, but warned that any extensions sought beyond 6 May would be "vigorously contested".

On 6 May 1991 Alcon lodged a further appliction for extension of time to 6 July 1991 which was accompanied by part of a sixth lot of evidence.  The remainder of this evidence was served on 15, 17 and 29 May, 24 June and 1 July 1991.  Allergan objected to this most recent application for extension and the matter was heard in Canberra on 3 July 1991.  Allergan was represented by Dr Peter Stearne, patent attorney with Davies & Collison, Melbourne and Alcon was represented by Mr Michael Houlihan, patent attorney with Callinan Lawrie, Melbourne.
Application for Extension
          The grounds upon which Alcon made its present application for extension of time are set out in some detail in its application lodged on 6 May 1991.  These grounds are summarised as follows:

"Our attorneys, Callinan Lawrie, have just received on 6 May 1991, a facsimile-transmitted copy of a Statutory Declaration by one of our Australian experts, Mr John P.F. Strachan.  The Strachan Declaration was facsimile-transmitted to Callinan Lawrie from Legian, Bali, where Mr Strachan is currently holidaying.  Mr Strachan, acting on a spur of the moment decision, left Australia for the Bali holiday on Sunday 28 April 1991 without advising Callinan Lawrie that he would be unavailable to finalise and subsequently complete his Statutory Declaration.  Consequently, upon completion of the final draft of the Strachan Declaration by Callinan Lawrie on 1 May 1991 (following considerable discussion and revision), Callinan Lawrie then contacted Mr Strachan's Melbourne Office only to be then advised that Mr Strachan was not in Australia and was on holiday in Bali.  Consequently, Callinan Lawrie then made…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Allergan Pharmaceuticals Inc v Alcon Laboratories (Australia... and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[1991] APO 36
Decision Date

CaseChat Overview and Summary

Allergan Pharmaceuticals Inc opposed Alcon Laboratories (Australia) Pty Ltd's patent application 588049 relating to the cleaning of contact lenses. Alcon had been granted multiple extensions to serve evidence-in-support, but Allergan objected to a final extension to 6 July 1991. The dispute went to a hearing before a delegate of the Commissioner of Patents.

The central legal issue was whether the delegate should grant Alcon's application for an extension of time to serve evidence-in-support. The delegate had to consider whether a serious opposition was in train, whether Alcon had made out a proper case justifying the extension, and whether the public interest would be served by allowing the extension.

The delegate found that Alcon was mounting a serious opposition given the volume of evidence served. While delays had occurred, Alcon had completed serving its evidence and made efforts to avoid unreasonable delays. The delegate accepted that Alcon had encountered unexpected difficulties gathering evidence from overseas experts, which justified the extension. Allowing the extension would better serve the public interest by enabling the merits of the patent application to be argued in light of the evidence. The delegate therefore allowed the extension and ordered costs against Allergan.

In summary, the delegate allowed the extension sought by Alcon after weighing the seriousness of the opposition, the reasonableness of the delays, and the public interest. The decision turned on the circumstances of Alcon's efforts to gather evidence and the completeness of the evidence served so far.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established